BRPI0913665B8 - composição para tratamento de pressão intraocular aumentada em um paciente, compreendendo extratos de vaccinum myrtillus e de casca de pinheiro - Google Patents

composição para tratamento de pressão intraocular aumentada em um paciente, compreendendo extratos de vaccinum myrtillus e de casca de pinheiro

Info

Publication number
BRPI0913665B8
BRPI0913665B8 BRPI0913665A BRPI0913665A BRPI0913665B8 BR PI0913665 B8 BRPI0913665 B8 BR PI0913665B8 BR PI0913665 A BRPI0913665 A BR PI0913665A BR PI0913665 A BRPI0913665 A BR PI0913665A BR PI0913665 B8 BRPI0913665 B8 BR PI0913665B8
Authority
BR
Brazil
Prior art keywords
intraocular pressure
extracts
patient
composition
pine bark
Prior art date
Application number
BRPI0913665A
Other languages
English (en)
Inventor
Burki Carolina
Schoenlau Frank
Malandrino Salvatore
Ferrari Victor
Original Assignee
Horphag Res Luxembourg Holding Sa
Horphag Res Ip Mir Ltd
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Horphag Res Luxembourg Holding Sa, Horphag Res Ip Mir Ltd, Indena Spa filed Critical Horphag Res Luxembourg Holding Sa
Publication of BRPI0913665A2 publication Critical patent/BRPI0913665A2/pt
Publication of BRPI0913665B1 publication Critical patent/BRPI0913665B1/pt
Publication of BRPI0913665B8 publication Critical patent/BRPI0913665B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

tratamento da pressão intraocular anormal. são descritos métodos e fórmulas para reduzir a pressão intraocular em pacientes, especialmente em pacientes humanos. discute-se, em especial, o fato de as fórmulas conterem uma unidade de antocianósidos ou extrato de unidades de antocianósidos, uma unidade de proantocianidinas ou extrato de unidades de proantocianidinas e suas combinações. as fórmulas são úteis para reduzir a pressão intraocular.
BRPI0913665A 2008-01-18 2009-01-16 composição para tratamento de pressão intraocular aumentada em um paciente, compreendendo extratos de vaccinum myrtillus e de casca de pinheiro BRPI0913665B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1156108P 2008-01-18 2008-01-18
US61/011,561 2008-01-18
PCT/EP2009/000255 WO2009090085A1 (en) 2008-01-18 2009-01-16 Abnormal intraocular pressure treatment

Publications (3)

Publication Number Publication Date
BRPI0913665A2 BRPI0913665A2 (pt) 2016-06-14
BRPI0913665B1 BRPI0913665B1 (pt) 2020-09-29
BRPI0913665B8 true BRPI0913665B8 (pt) 2021-05-25

Family

ID=40394172

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0913665A BRPI0913665B8 (pt) 2008-01-18 2009-01-16 composição para tratamento de pressão intraocular aumentada em um paciente, compreendendo extratos de vaccinum myrtillus e de casca de pinheiro

Country Status (14)

Country Link
US (2) US20110046215A1 (pt)
EP (1) EP2252285B1 (pt)
JP (1) JP5643111B2 (pt)
KR (1) KR101516706B1 (pt)
CN (1) CN101951899B (pt)
AU (1) AU2009204944B2 (pt)
BR (1) BRPI0913665B8 (pt)
CA (1) CA2711964C (pt)
DK (1) DK2252285T3 (pt)
ES (1) ES2542176T3 (pt)
HK (1) HK1150966A1 (pt)
MX (1) MX2010007828A (pt)
RU (1) RU2481833C2 (pt)
WO (1) WO2009090085A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103110686B (zh) * 2013-02-04 2016-03-23 广州花海药业股份有限公司 一种治疗糖尿病性视网膜病变的药物及其制备方法
NZ737567A (en) * 2015-05-25 2022-10-28 Arborvitae Health And Wellbeing Pty Ltd Composition and uses thereof
CN116211913A (zh) * 2017-10-04 2023-06-06 参天制药株式会社 含有越橘果实的加工产物和松树皮的加工产物的用于保护视网膜神经细胞的组合物
RU2693899C1 (ru) * 2018-09-06 2019-07-05 Общество с ограниченной ответственностью "Медикал Инновэйшн Технолоджи" Лекарственное средство для лечения и профилактики высокого внутриглазного давления
US10849948B2 (en) 2019-04-16 2020-12-01 The Procter & Gamble Company Supplement for menopause

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002533379A (ja) * 1998-12-23 2002-10-08 イデア アクチェンゲゼルシャフト 生体内における局所的に非侵襲性である用途のための改善された製剤
AU5136100A (en) * 1999-05-17 2000-12-05 Avi Biopharma, Inc. Combined approach to treatment of cancer with hcg vaccines
US6573299B1 (en) * 1999-09-20 2003-06-03 Advanced Medical Instruments Method and compositions for treatment of the aging eye
WO2002020028A2 (en) * 2000-09-06 2002-03-14 Braswell A Glenn Method and composition for enhancing vision
RU2196594C2 (ru) * 2000-09-25 2003-01-20 Общество с ограниченной ответственностью "Камелия НПП" Средство, обладающее восстановительным, тонизирующим и регенераторным действием
US6583152B2 (en) * 2001-04-30 2003-06-24 Dexgen Pharmaceuticals, Inc. Composition for reducing the risk or progression of cardiovascular diseases
US7270835B2 (en) * 2001-06-20 2007-09-18 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
CA2519028A1 (en) * 2002-04-03 2003-10-16 Maureen A. Mckenzie Vaccinium species compositions with novel beneficial properties
US20050163873A1 (en) * 2004-01-14 2005-07-28 Robert Ritch Methods and formulations for treating glaucoma
US20080181972A1 (en) * 2007-01-29 2008-07-31 Valentina Amico Compositions and Methods for Maintaining, Strengthening, Improving, or Promoting Eye Health

Also Published As

Publication number Publication date
WO2009090085A8 (en) 2010-08-26
AU2009204944B2 (en) 2013-10-24
US20130244961A1 (en) 2013-09-19
DK2252285T3 (en) 2015-07-13
CN101951899A (zh) 2011-01-19
US9125925B2 (en) 2015-09-08
HK1150966A1 (en) 2012-01-20
EP2252285B1 (en) 2015-04-15
ES2542176T3 (es) 2015-07-31
MX2010007828A (es) 2010-12-17
RU2481833C2 (ru) 2013-05-20
US20110046215A1 (en) 2011-02-24
EP2252285A1 (en) 2010-11-24
CA2711964C (en) 2017-06-20
JP5643111B2 (ja) 2014-12-17
KR101516706B1 (ko) 2015-05-04
KR20100111294A (ko) 2010-10-14
AU2009204944A1 (en) 2009-07-23
RU2010134503A (ru) 2012-02-27
JP2011509965A (ja) 2011-03-31
BRPI0913665B1 (pt) 2020-09-29
BRPI0913665A2 (pt) 2016-06-14
WO2009090085A1 (en) 2009-07-23
CN101951899B (zh) 2012-12-05
CA2711964A1 (en) 2009-07-23

Similar Documents

Publication Publication Date Title
BR112013000027A2 (pt) tratamento de distúrbios cognitivos
BRPI0909749A2 (pt) uso de fotoiniciador para fabrico de medicamento para tratamento do ceratocone, da ectasia e fortalecimento da córnea
BRPI1007379B8 (pt) composições farmacêuticas para o tratamento ou prevenção de infecções orais por e. coli
AR093386A1 (es) Composicion para tratar la diabetes o la diabesidad que comprende un analogo de oxintomodulina y metodo de tratamiento
WO2009034559A3 (en) Cosmetic process for aesthetic and/or repairing treatment of the skin
CL2008000725A1 (es) Compuestos derivados de heterociclos aromaticos; composicion farmaceutica; kit farmceuticos; uso de la composicion y de los compuestos como inhibidores de glucano sintasa para el tratamiento o prevencion del crecimiento de patogenos fungicos en planta y para tratar o prevenir infecciones producidas por hongos.
MX340515B (es) Terapia antidiabética vasoprotectora y cardioprotectora.
BR112012006692A2 (pt) composição farmacêutica compreendendo ácido graxo de omega-3 e um derivado de hidróxi de uma estatina e métodos de uso das mesmas
CR11731A (es) Composiciones y procedimientos para su preparación y uso
PE20160949A1 (es) Cepa aislada de clonostachys rosea para uso como agente de control biologico
CO6300844A2 (es) Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasa
ATE456369T1 (de) Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
BR112012006468A2 (pt) métodos de tratamento de inflamação
BRPI0916985A2 (pt) composto de tetraciclina c7-fluoro substituído, composição farmacêutica que o compreende e método para o tratamento ou prevenção de uma infecção ou colonização em um paciente
WO2010062581A3 (en) A botanical composition for enhanced skin repair and uses thereof
NI201200090A (es) Composiciones para tratar náusea y vómito centralmente mediados
BRPI0913665B8 (pt) composição para tratamento de pressão intraocular aumentada em um paciente, compreendendo extratos de vaccinum myrtillus e de casca de pinheiro
BR112012010061A2 (pt) utilização de um extrato de punica granatum para combater a canície
ECSP088745A (es) Derivados sustituidos de cromanol y su uso
CL2012003266A1 (es) Polisacarido de semillas de tamarindo para usarse en el tratamiento de infecciones microbianas; composicion farmacéutica y/o dermocosmética antimicrobiana que contiene dicho polisacárido; uso de un polisacárido de semilla de tamarindo ; metodo para tratar y/o prevenir a un paciente que tiene una infeccion microbiana.
WO2011044523A3 (en) Compositions and methods for treating obesity
BR112012021383A2 (pt) tratamento ou prevencao de infeccao
ECSP10010464A (es) Uso de ranolazina para el tratamiento de enfermedades cardiovasculares
BR112021018222A2 (pt) Composição
BR112012028153A2 (pt) composição farmacêutica e método para o tratamento de hipertensão

Legal Events

Date Code Title Description
B15I Others concerning applications: loss of priority

Free format text: PERDA DA PRIORIDADE US 61/011,561 DE 18/01/2008, CONFORME AS DISPOSICOES PREVISTAS NA LEI 9.279 DE 14/05/1996 (LPI) ART. 16 7O E NO ART. 28 DO ATO NORMATIVO 128/1997, POR NAO ATENDER AO DISPOSTO NO ART. 27 DO ATO NORMATIVO 128/1997, POIS NAO FOI APRESENTADA CESSAO DA REFERIDA PRIORIDADE, QUE POSSUI DEPOSITANTE DIFERENTE DO DEPOSITANTE DA FASE NACIONAL.

B12F Other appeals [chapter 12.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: INDENA S.P.A. (IT) , HORPHAG RESEARCH IP (MIR) LTD (CY)

Owner name: INDENA S.P.A. (IT) , HORPHAG RESEARCH IP (MIR) LTD

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 29/09/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/01/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF